Kronos Bio, Inc. (KRON)
NASDAQ: KRON · Real-Time Price · USD
0.8899
-0.0027 (-0.30%)
At close: Jun 16, 2025, 4:00 PM
0.8860
-0.0039 (-0.44%)
After-hours: Jun 16, 2025, 4:01 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Dysregulated Transcription Therapeutics
6.29M

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
6.29M